Navigation Links
Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive
Date:10/6/2011

NEW YORK, Oct. 6, 2011 /PRNewswire/ -- Avista Capital Partners, a leading private equity firm, today announced that it has hired Hakan Bjorklund, the departing Chief Executive Officer of Nycomed, as Healthcare Operating Executive.  Mr. Bjorklund worked closely with Avista on the development of Nycomed during Avista's ownership of the company, which was recently sold to Takeda Pharmaceuticals Company Limited for Euro 9.6 billion.

Under Mr. Bjorklund's leadership, Nycomed was transformed from a predominantly Scandinavian business into a global pharmaceutical company with leading market positions in Europe, Russia/CIS, Brazil and Latin America.  In 2006, Mr. Bjorklund led the integration of Altana Pharmaceutical, a German-based company that Nycomed purchased for Euro 4.2 billion. He was also instrumental in growing Nycomed in emerging markets, most recently through the acquisition of Guangdong Techpool Bio-Pharma Co., Ltd, a fast growing Chinese bio-pharmaceutical company, in 2010.    

Thompson Dean, Co-Managing Partner and Chief Executive Officer of Avista, said, "We are delighted to welcome Hakan to Avista.  One of the top pharmaceutical executives in Europe, he possesses a deep understanding of the global healthcare market.  Having worked closely with him for many years, I know that Hakan will bring extensive strategic, operational and investment expertise to Avista as well as strong relationships throughout the global healthcare sector."    

Newton Aguiar, the partner in charge of Avista's European operations, added, "We are looking forward to working with Hakan on healthcare investments both in Europe and throughout the world.  Hakan built Nycomed into one of the fastest growing global pharmaceutical companies, in part, by expanding its presence in key emerging markets, particularly in Russia/CIS and Latin America.  His experience will be invaluable to the healthcare management teams in Avi
'/>"/>

SOURCE Avista Capital Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ARAMARK Agrees to Sell its Galls Business to CI Capital Partners
2. Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding
3. K-V Pharmaceutical Company to Present at Imperial Capitals 5th Annual Global Opportunities Conference
4. Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix
5. Thoratec Presentation at Lazard Capital Markets Circulatory Assist Device Day to be Webcast
6. HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day
7. HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market
8. Main Street Capital Announces New Portfolio Investment
9. MGT Capital Investments, Inc.s Plan of Compliance Accepted by NYSE AMEX, LLC
10. CVS Caremark Corporation Announces Receipt of Requisite Consents, Termination of Replacement Capital Covenant and Expiration of Consent Solicitation Relating to its 6.125% Senior Notes due August 15, 2016 (CUSIP NO. 126650BE9)
11. MGT Capital Investments, Inc. Provides Update on Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
(Date:8/28/2014)... Levi & Korsinsky announces that a class ... District Court for the District of Nevada ... Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt . ... Period the Company violated federal securities laws by issuing ...
(Date:8/28/2014)... , August 28, 2014 ... titled, "DNA diagnostics Market (products, applications, techniques, end ... Opportunities, Growth and Forecast, 2013 - 2020," indicates ... $19 billion by 2020 registering a CAGR of ... provide accurate diagnosis and cost effectiveness over alternative ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
... Cephalon, Inc. (Nasdaq: CEPH ) today announced ... priority review for its supplemental New Drug Application (sNDA) for ... of this year. The FDA decision on approval of NUVIGIL ... sleepiness associated with jet lag disorder due to eastbound travel ...
... , NEW YORK, Sept. 24 "Today marks ... now have evidence that it is possible to reduce the risk ... Warren, reacting to the results of the first AIDS vaccine trial ... and resources to fully analyze, understand and validate the data, but ...
Cached Medicine Technology:Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder 4AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study 2AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study 3AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study 4AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study 5
(Date:8/29/2014)... NZ (PRWEB) August 29, 2014 The ... Greg Allen to Chief Executive Officer effective from 1st ... Technology Officer for Winscribe. , “During this time of ... than Greg Allen,” said Matthew Weavers, Winscribe’s Founder and ... with a wealth of commercial, IT and management experience ...
(Date:8/28/2014)... VPS (Virtual Private Server) is ... into many servers, each of which has the ... dedicated computer. Top10BestSEOHosting.com has recently compared many professional ... http://www.top10bestseohosting.com/go/GoDaddy.com/ ), Bluehost and IX Web Hosting are ... The IT manager of Top10BestSEOHosting.com says, “These companies ...
(Date:8/28/2014)... 2014 When David Gergen, President of ... of Mark Brnovich, was asked to publicly support Mr. ... the Attorney General seat in the State of Arizona, ... support of Cardinal Hall of Fame wide receiver Roy ... and Mark Walczak. Green, Kennard and Walczak are members ...
(Date:8/28/2014)... Arlington, Massachusetts (PRWEB) August 29, 2014 ... company that solves some of the healthcare industry's ... design concepts that radically rethink health. Involution ... edge of technology creating software solutions for clients ... and Walgreens. , As part of the studio's ...
(Date:8/28/2014)... 28, 2014 On August 21, the ... its 2013 Annual Report, featuring the organization’s audited financial ... , According to the report, in 2013, the ... programs versus 14 cents on fundraising and administration. ... a minimum,” wrote the Foundation’s chief executive officer, Melinda ...
Breaking Medicine News(10 mins):Health News:Winscribe Names Greg Allen as CEO 2Health News:Top10BestSEOHosting.com Announces The Best Three VPS Hosting Suppliers 2Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Mesothelioma Applied Research Foundation’s Annual Report 2013 Release 2
... 8-year-old boy,living with epilepsy, and his mother Amy receive ... the exclusive sponsor of Canine,Assistants seizure response dogs. Through ... to play sports, take,music lessons, and learn Tae Kwon ... when his parents are not around is still a ...
... quick, non-invasive identification of the dangerous disease , , WEDNESDAY, ... be able to accurately, rapidly, and non-invasively diagnose lung ... the mouth, a new study suggests. , Oral cavity ... to be a highly accurate indicator of similar lung ...
... Mass., April 16 Xceed Molecular, a ... analysis,systems, announced that the University of Florida ... work with primary researchers,Charles Joel Rosser, MD ... of Surgery), to perform initial verification and ...
... Required to Provide Calorie Information, ALEXANDRIA, Va., ... today,s federal court ruling upholding,a New York City ... content of foods on their menus and menu ... to the regulation filed by the New York ...
... MONICA, Calif., April 16 Consumer,Watchdog today joined ... lawsuit alleging that health insurer Blue Cross engaged ... insurance of patients,after they got sick., The ... at least hundreds,of patients who have been left ...
... 16 MedCath Corporation,(Nasdaq: MDTH ) announced today ... of Directors., Mr. Grossman brings a wealth of ... Directors. He served as partner and health care,practice leader ... years with the firm. While with Pricewaterhouse Coopers, he ...
Cached Medicine News:Health News:Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 3Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 2Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 3Health News:Statement of the American Diabetes Association Supporting Federal Court's Ruling on New York City Proposal 2Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same 2Health News:Woodrin 'Woody' Grossman Appointed to MedCath's Board of Directors 2
... Personal Micro Centrifuges MiniSpin and MiniSpin plus ... they are powerful enough so that each ... centrifuge for a wide range of molecular ... are available to meet your performance requirements. ...
Inquire...
Spectrafuge 24D High speed, digital microcentrifuge. Precision control with digital display. Easy access 24-place rotor. Set and view speed in rpm or rcf. Quiet and cool running. StripSpin adapter fo...
... Separating Power , Micromax produces forces up to ... 24 (1.5-2.0 mL) samples or 48 (0.5 mL) ... motor is designed for longevity and requires no ... In addition, all controls are microprocessor based for ...
Medicine Products: